The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TASMX | 29.23 | -0.10 | -0.34% |
| Transamerica Small/Mid Cap Value R6 | |||
| NUGIX | 34.71 | -0.15 | -0.43% |
| Nuveen Global Dividend Growth I | |||
| AEYGX | 35.97 | -0.42 | -1.15% |
| American Century Equity Growth R5 | |||
| PLGAX | 13.45 | -0.35 | -2.54% |
| Principal LargeCap Growth I A | |||
| DAFGX | 31.46 | -0.90 | -2.78% |
| Dunham Focused Large Cap Growth A | |||
A.I.dvisor indicates that over the last year, ADNRX has been closely correlated with FSMAX. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if ADNRX jumps, then FSMAX could also see price increases.
| Ticker / NAME | Correlation To ADNRX | 1D Price Change % | ||
|---|---|---|---|---|
| ADNRX | 100% | -1.27% | ||
| FSMAX - ADNRX | 86% Closely correlated | N/A | ||
| RPTIX - ADNRX | 72% Closely correlated | -1.13% | ||
| RPMGX - ADNRX | 72% Closely correlated | -1.13% | ||
| PAMCX - ADNRX | 72% Closely correlated | -1.13% | ||
| RRMGX - ADNRX | 71% Closely correlated | -1.14% | ||
More | ||||